HAEK — Haemato AG Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- €53.68m
- €30.71m
- €248.14m
Annual income statement for Haemato AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 274 | 198 | 238 | 285 | 248 |
| Cost of Revenue | |||||
| Gross Profit | 21.1 | 13.6 | 17.7 | 30.7 | 21.6 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 266 | 198 | 237 | 274 | 240 |
| Operating Profit | 8.5 | -0.019 | 1.63 | 11.2 | 8.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 7.76 | -1.19 | -4.56 | 9.36 | 10.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 6.28 | -1.17 | -4.83 | 6.53 | 8.19 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 6.28 | -1.17 | -4.83 | 6.53 | 8.19 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 6.28 | -1.17 | -4.83 | 6.53 | 8.19 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.8 | -0.513 | -2.02 | 1.28 | 1.57 |
| Dividends per Share |